상세 보기
Patient-reported outcomes (PROs) from the SERENA-6 trial of camizestrant (CAMI)+CDK4/6 inhibitor (CDK4/6i) for emergent ESR1m during first-line (1L) endocrine-based therapy and ahead of disease progression in patients (pts) with HR+/HER2-advanced breast cancer (ABC)
- Mayer, E.;
- Bidard, F. C.;
- Park, Y. H.;
- Janni, W.;
- Ma, C. X.;
- 외 15명
Citations
WEB OF SCIENCE
0Citations
SCOPUS
0- 제목
- Patient-reported outcomes (PROs) from the SERENA-6 trial of camizestrant (CAMI)+CDK4/6 inhibitor (CDK4/6i) for emergent ESR1m during first-line (1L) endocrine-based therapy and ahead of disease progression in patients (pts) with HR+/HER2-advanced breast cancer (ABC)
- 저자
- Mayer, E.; Bidard, F. C.; Park, Y. H.; Janni, W.; Ma, C. X.; Cristofanilli, M.; Bianchini, G.; Iwata, H.; Fasching, P. A.; Brufsky, A. M.; Nowecki, Z.; Pascual, J.; Moreau, L.; Chen, S. C.; Karadurmus, N.; Arizmendi, C.; Fox, S.; Miralles, M. Selvi; Bartlett, C.; Turner, N. C.
- 발행일
- 2025-09
- 유형
- Meeting Abstract
- 권
- 36